Emerging CAR-T therapies for T-cell lymphoma
2 Views
administrator
07/14/23
Emmanuel Bachy, MD, PhD, Lyon Sud Hospital Center, Lyon, France, outlines novel promising CAR-T therapies in development for the treatment of T-cell lymphoma, including a CAR-T directed against the constant fraction of the T-cell receptor (TCR) and an allogeneic product directed against CD70. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
Show more
Facebook Comments
No comments found